ZOE

Vitamin D production through sunlight in summer is real and beneficial for bone health, but the link with bones is more nuanced than the claim suggests. Research shows that vitamin D alone does not demonstrably prevent bone fractures; only in combination with calcium is there a measurable effect, and even then primarily in older people at increased risk. Moreover, whether twenty minutes with bare forearms is enough for a 'significant' boost depends on factors such as skin type, latitude and time of day, and that nuance is absent from the claim.

Weight-bearing and dynamic exercise such as running and strength training does demonstrably stimulate bone formation, and the biological explanation for this is reasonably well established. The second part of the claim goes beyond what the available research supports: a direct comparison between swimming and running is lacking, so saying there is "no effect" is a stronger statement than the current science warrants. What is known is that activities without impact loading, such as swimming and cycling, stimulate the bones less or not at all, and that intensive cycling has even been linked to lower bone density.

A slightly higher body weight can stimulate bone density through mechanical loading, but the relationship is far from as straightforward as this claim suggests. A large amount of abdominal fat and a high fat-to-weight ratio are actually linked to lower bone density and a higher risk of osteoporosis. The role of oestrogen production in fatty tissue and the cushioning effect during a fall are not confirmed by research as well-supported protective mechanisms, and the location and composition of the fat largely determine whether or not the skeleton benefits.

Excessive alcohol use demonstrably harms your bones, that much is true. However, the idea that drinking in moderation is better than abstaining altogether is not supported by the available research. Large studies consistently show that less alcohol leads to better health outcomes, and international health organizations do not recognize a safe lower threshold. The claim implies a J-shaped curve in which moderate drinkers fare best, but that pattern has not been demonstrated specifically for bone health in the existing evidence.

The part about cortisol is solidly substantiated: prolonged elevated cortisol levels, as seen with corticosteroid use, impair bone formation through several simultaneous mechanisms, and this has been well documented for decades. For chronic low-grade inflammation as an independent driver of bone resorption, the available research provides no direct support, even though it is plausible that the mechanism works in the same direction. The claim thus combines two processes that each carry a different level of evidence, making the formulation go further than what can be firmly established.

Bone loss begins around the age of thirty, which aligns with the broader picture that peak bone mass is reached around that age, after which the balance between formation and resorption shifts. Research describes this as a well-established and widely documented biological process. The claim that bone mass can also stabilise after that age is correct: with intensive strength training, some bone formation or maintenance in adulthood is still possible, although the effect diminishes with age and in older people it is more often a matter of slowing down loss than of genuine growth.

It is well established that a hip fracture significantly increases the risk of death: in the first year after the fracture, the mortality risk is nearly three times higher than in peers without a fracture, and that elevated risk persists for years afterwards. The claim that 'about one third' die within a given period is not implausible in that direction, but that precise figure cannot be substantiated on the basis of the available research. Moreover, the risk varies considerably from person to person: men, people with dementia and people with multiple chronic conditions face considerably greater danger than others.

The general direction of this claim is correct: fibre in whole fruit slows the absorption of sugars, and fructose from whole fruit appears to have more favourable effects than free fructose in drinks or processed products. This is also reflected in research comparing fruit juice with whole fruit, where whole fruit consistently scores better on sugar profile and satiety. However, the specific leap to "less inflammatory damage" goes beyond what the available evidence shows: a direct link between fibre, fructose metabolism and a measurable difference in inflammation has not yet been conclusively demonstrated in humans. The claim describes a plausible mechanism, but presents it with more certainty than the evidence warrants.

Gut bacteria do indeed convert dietary fibre into short-chain fatty acids, and that process has demonstrable benefits for the intestinal lining and digestion. Butyrate is one of those short-chain fatty acids, but the claim goes a step further by labelling them 'anti-inflammatory': the link with inflammation in the body is plausible but less straightforward than suggested. How strong the effect is varies considerably from person to person and depends on which bacteria are already present in someone's gut.

Visceral fat is indeed not a passive fat store: it actively releases inflammatory substances and fatty acids into the bloodstream, thereby contributing to chronic, low-grade inflammation. Excess weight leads to elevated inflammatory markers through fat tissue, gut flora, and the liver simultaneously, and that pattern is biologically well understood and consistently found in research. The claim that immune cells are specifically 'attracted' by visceral fat and that this causes 'persistent' inflammation goes slightly beyond what the available evidence precisely states: the mechanisms have been demonstrated, but the exact role of immune cell recruitment by visceral fat in isolation is less clearly defined in the research than the claim suggests.

That chronic low-grade inflammation accelerates biological ageing is well supported: multiple mechanisms such as DNA methylation, telomere shortening and inflammatory markers all point in the same direction, and inflammation and cellular ageing appear to reinforce each other mutually. The second part of the claim, that this shortens lifespan, goes beyond what research can establish with certainty. The associations with serious diseases such as cancer, cardiovascular disease and dementia are plausible, but a direct causal link between low-grade inflammation and a shorter lifespan in humans has not yet been causally proven.

That nuts reduce the risk of cardiovascular disease is well supported by multiple large meta-analyses and a substantial study. However, the figure of 30% risk reduction cannot be substantiated on the basis of the available research. Moreover, the evidence says something about nuts as part of a varied diet, not specifically about replacing processed snacks with nuts as a standalone strategy.

Animal and laboratory research shows that artificial sweeteners can affect blood sugar regulation, but small studies in healthy people do not consistently find this effect. For saccharin and sucralose specifically, the claim is stronger than the research justifies: the available studies contradict one another and there is no scientific consensus. The direction of the claim is therefore not without basis, but the phrase 'negatively affect' suggests more certainty than the current evidence supports.

Several large observational studies do indeed show that high consumption of ultra-processed food is linked to greater risks of cardiovascular disease, diabetes and depression. For cancer, the association is more specific than the claim suggests: the evidence points mainly to sugar-sweetened beverages and an increased risk of certain types of cancer, not cancer in general. Moreover, causality has not been conclusively established anywhere, and the risk depends strongly on the type of ultra-processed product and your overall diet.

Not a single study has tested the cortisol cocktail, also known as the adrenal cocktail, as a product in humans. Moreover, the popular assumption behind it, that stress leads to a cortisol deficiency that can be replenished with such a drink, is incorrect: studies on chronic fatigue and stress actually show elevated cortisol levels. The claim that there is no scientific evidence for lowering cortisol levels through such a cocktail is therefore supported by the available research.

Research shows that regular alcohol consumption chronically raises cortisol levels, which supports the core of the claim. The available evidence says nothing concrete about inflammation. The phrasing that alcohol does not physiologically reduce stress is accurate in the sense that alcohol actually drives stress hormones up rather than suppressing them, but the claim implies this is the full picture, while the inflammatory aspect is not supported by the evidence cited here.

Research shows that fermented dairy products such as yoghurt and kefir do indeed have the strongest clinical evidence for a positive effect on the diversity of gut bacteria and inflammatory markers. However, that evidence comes mainly from smaller studies and does not automatically apply to all fermented dairy products. The claim is therefore largely correct for yoghurt, but is slightly too categorical because the evidence is still limited and the effects can vary by product and by person.